Researchers have developed a stool-based test that detects colorectal cancer with 90% accuracy, potentially offering patients an alternative to invasive colonoscopy screening.
The breakthrough centers on analyzing patterns in gut bacteria using artificial intelligence. Scientists mapped microbial communities in stool samples at unprecedented resolution, identifying specific bacterial signatures that correlate with cancer presence.
The detection rate matches the performance of colonoscopy, long considered the gold standard for identifying colorectal tumors. If validated further, the approach could reshape screening practices by eliminating the need for the uncomfortable procedure that many patients delay or avoid.
The method works by examining the composition and behavior of naturally occurring microbes in the digestive tract. Cancer appears to alter these bacterial communities in measurable ways. Machine learning algorithms trained on large datasets can now recognize these cancer-associated patterns from a simple stool sample.
Colorectal cancer remains one of the leading causes of cancer deaths globally, with early detection significantly improving survival rates. Current screening typically requires either colonoscopy every 10 years or alternative tests like fecal immunochemical tests, which are less sensitive.
Researchers say the new approach could increase screening participation by offering a non-invasive option that patients might find more acceptable. The test requires only a stool sample collected at home, eliminating preparation requirements and procedural anxiety associated with colonoscopy.
Next steps involve larger clinical trials to confirm the findings across diverse populations and validate the test's performance in real-world settings. If successful, the technology could eventually become a standard screening tool, though colonoscopy would likely remain necessary for patients with positive results to enable biopsy and removal of polyps.
Comments